ERIN LECHNER: Open Payments
NPI 1417781634 · NEW CASTLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,543 in 76 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $148 · 2025 $1,543
Food & beverage: $1,511Education: $33
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $373 |
| Lilly USA, LLC | 10 | $219 |
| PFIZER INC. | 6 | $128 |
| Amgen Inc. | 6 | $109 |
| GlaxoSmithKline, LLC. | 6 | $104 |
| ABBVIE INC. | 5 | $93 |
| Axsome Therapeutics, Inc. | 3 | $80 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Esperion Therapeutics, Inc. | 3 | $48 |
| Lundbeck LLC | 2 | $40 |
Products named: Ozempic, MOUNJARO, PREVNAR 20, Auvelity, TRELEGY ELLIPTA, UBRELVY, REXULTI, NEXLETOL.
Industry payments across PA — which companies pay providers there.
